Cheilitis granulomatosa

Dermatol Online J. 2011 Oct 15;17(10):15.

Abstract

Melkersson-Rosenthal Syndrome (MRS) is a rare syndrome that is characterized by a triad of facial paralysis, chronic edema of the lip, and a fissured tongue. Most commonly, one element of the triad precedes the development of the other symptoms. We present a case of cheilitis granulomatosa (CG) as a manifestation of incomplete MRS. As the etiology remains unknown, treatment of CG is challenging. Intralesional glucocorticoids remain the first-line treatment, but recurrences are common. We discuss alternative treatment strategies that include combination therapy with other anti-inflammatory agents and biologics, such as infliximab.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Adult
  • Anti-Inflammatory Agents / administration & dosage
  • Anti-Inflammatory Agents / therapeutic use
  • Antibodies, Monoclonal / therapeutic use
  • Biopsy
  • Crohn Disease
  • Female
  • Humans
  • Infliximab
  • Injections, Intralesional
  • Lidocaine / administration & dosage
  • Lip / pathology
  • Melkersson-Rosenthal Syndrome / diagnosis*
  • Melkersson-Rosenthal Syndrome / drug therapy
  • Syndrome
  • Triamcinolone / administration & dosage
  • Triamcinolone / therapeutic use
  • Tumor Necrosis Factor-alpha / physiology

Substances

  • Anti-Inflammatory Agents
  • Antibodies, Monoclonal
  • Tumor Necrosis Factor-alpha
  • Triamcinolone
  • Lidocaine
  • Infliximab